Price T Rowe Associates Inc Athira Pharma, Inc. Transaction History

Price T Rowe Associates Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$9.15 - $11.09 $4.08 Million - $4.94 Million	-445,655 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$10.24 - $20.87 $2.33 Million - $4.74 Million	-227,307 Reduced 33.78%	445,655 $4.56 Million
Q1 2021 May 17, 2021	SELL	$16.9 - $29.77 $145,306 - $255,962	-8,598 Reduced 1.26%	672,962 $12.4 Million
Q4 2020 Feb 16, 2021	BUY	$16.48 - $34.3 $11.2 Million - $23.4 Million	681,560 New	681,560 $23.3 Million

16.9M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $24.2M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.